{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:13:15Z","timestamp":1779095595986,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cientificas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>African horse sickness (AHS) is a highly severe, midge-borne disease of equids showing a mortality rate of\u2009&gt;\u200990% in naive domestic horses. Outbreaks are caused by AHS virus (AHSV) and result in devastating economic losses in developing countries as equids play a crucial role in the agricultural industry and many households. The AHSV species encompasses nine serotypes showing no or limited cross protection, which is challenging regarding AHS vaccine development. Recently, and like bluetongue virus (BTV), the AHS Disabled Infectious Single Animal (DISA)-DIVA vaccine platform was developed and applied for all nine AHSV serotypes. The vaccine platform is based on a single deletion crucial for vaccine safety and affording differentiation of infected from vaccinated individuals (DIVA) testing. Before considering ethically debatable and expensive experiments in equids, DISA-DIVA vaccine candidates were evaluated here in the previously validated IFNAR (-\/-) mouse model for AHS. A multivalent AHS DISA-DIVA vaccine containing DISA constructs for each of the nine serotypes was studied. This \"DISA cocktail\" was safe and protected mice against two virulent AHSV serotypes used in challenge infection studies. DISA multivalent vaccine induced serotype-specific neutralizing antibodies (nAbs) against all AHSV serotypes suggesting broad protection, as correlates of protection (CoP) based on nAb titers for studied serotypes can be extrapolated to others. These results now justify further experiments in horses to study safety, efficacy and DIVA by DISA cocktail vaccine. Importantly, the presented results for IFNAR (-\/-) mice indicate that broad protection of equines by vaccination with DISA cocktail vaccine can be feasible.<\/jats:p>","DOI":"10.1186\/s13567-026-01753-7","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:45:20Z","timestamp":1776307520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multivalent Disabled Infectious Single Animal (DISA)-DIVA vaccine for all nine serotypes of African horse sickness virus (AHSV) is broadly protective in IFNAR (-\/-) mice"],"prefix":"10.1186","volume":"57","author":[{"given":"Sergio","family":"Utrilla-Trigo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Jim\u00e9nez-Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 G. P.","family":"van Gennip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet A.","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ortego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Calvo-Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"1753_CR1","unstructured":"WOAH World Organisation for Animal Health. (2024). Terrestrial Animal Health Code: Chapter 1.3. Diseases, Infections and Infestations Listed by WOAH. Available online: https:\/\/www.woah.org\/en\/what-we-do\/standards\/codes-and-manuals\/terrestrial-code-online-access\/?id=169&L=1&htmfile=chapitre_oie_listed_disease.htm. Accessed 26 Dec 2024."},{"key":"1753_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s0749-0739(17)30402-9","volume":"9","author":"JA House","year":"1993","unstructured":"House JA (1993) African horse sickness. Vet Clin North Am Equine Pract 9:355\u2013364. https:\/\/doi.org\/10.1016\/s0749-0739(17)30402-9","journal-title":"Vet Clin North Am Equine Pract"},{"key":"1753_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cveq.2014.11.007","volume":"31","author":"JR Gilkerson","year":"2015","unstructured":"Gilkerson JR, Bailey KE, Diaz-M\u00e9ndez A, Hartley CA (2015) Update on viral diseases of the equine respiratory tract. Vet Clin North Am Equine Pract 31:91\u2013104. https:\/\/doi.org\/10.1016\/j.cveq.2014.11.007","journal-title":"Vet Clin North Am Equine Pract"},{"key":"1753_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.20506\/rst.34.2.2359","volume":"34","author":"S Zientara","year":"2015","unstructured":"Zientara S, Weyer CT, Lecollinet S (2015) African horse sickness. Rev Sci Tech 34:315\u2013327. https:\/\/doi.org\/10.20506\/rst.34.2.2359","journal-title":"Rev Sci Tech"},{"key":"1753_CR5","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001782","author":"J Matthijnssens","year":"2022","unstructured":"Matthijnssens J, Attoui H, B\u00e1nyai K, Brussaard CPD, Danthi P, Del Vas M, Dermody TS, Duncan R, F\u0101ng Q, Johne R,\u00a0Mertens PPC, Mohd Jaafar F, Patton JT, Sasaya T, Suzuki N, Wei T (2022) ICTV virus taxonomy profile: sedoreoviridae 2022. J Gen Virol 103:001782\u00a0https:\/\/doi.org\/10.1099\/jgv.0.001782","journal-title":"J Gen Virol"},{"key":"1753_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.5.1.1-7.1970","volume":"5","author":"DW Verwoerd","year":"1970","unstructured":"Verwoerd DW, Louw H, Oellermann RA (1970) Characterization of Bluetongue virus ribonucleic acid. J Virol 5:1\u20137","journal-title":"J Virol"},{"key":"1753_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/26694","volume":"395","author":"JM Grimes","year":"1998","unstructured":"Grimes JM, Burroughs JN, Gouet P, Diprose JM, Malby R, Zi\u00e9ntara S, Mertens PP, Stuart DI (1998) The atomic structure of the Bluetongue virus core. Nature 395:470\u2013478. https:\/\/doi.org\/10.1038\/26694","journal-title":"Nature"},{"key":"1753_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0042-6822(69)90361-4","volume":"38","author":"DW Verwoerd","year":"1969","unstructured":"Verwoerd DW (1969) Purification and characterization of Bluetongue virus. Virology 38:203\u2013212. https:\/\/doi.org\/10.1016\/0042-6822(69)90361-4","journal-title":"Virology"},{"key":"1753_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF01347976","volume":"47","author":"PS Mellor","year":"1975","unstructured":"Mellor PS, Boorman J, Jennings M (1975) The multiplication of African horse-sickness virus in two species of Culicoides (Diptera, Ceratopogonidae). Arch Virol 47:351\u2013356. https:\/\/doi.org\/10.1007\/BF01347976","journal-title":"Arch Virol"},{"key":"1753_CR10","first-page":"7","volume":"19","author":"RM Du Toit","year":"1944","unstructured":"Du Toit RM (1944) The transmission of Blue-tongue and Horse-sickness by Culicoides. J Vet Sc Anim Ind 19:7\u201316","journal-title":"J Vet Sc Anim Ind"},{"key":"1753_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027987","volume":"6","author":"S Carpenter","year":"2011","unstructured":"Carpenter S, Wilson A, Barber J, Veronesi E, Mellor P, Venter G, Gubbins S (2011) Temperature dependence of the extrinsic incubation period of orbiviruses in Culicoides biting midges. PLoS One 6:e27987. https:\/\/doi.org\/10.1371\/journal.pone.0027987","journal-title":"PLoS ONE"},{"key":"1753_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7589\/0090-3558-13.1.9","volume":"13","author":"NM Foster","year":"1977","unstructured":"Foster NM, Breckon RD, Luedke AJ, Jones RH (1977) Transmission of two strains of epizootic hemorrhagic disease virus in deer by Culicoides variipennis. J Wildl Dis 13:9\u201316. https:\/\/doi.org\/10.7589\/0090-3558-13.1.9","journal-title":"J Wildl Dis"},{"key":"1753_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrmicro1090","volume":"3","author":"BV Purse","year":"2005","unstructured":"Purse BV, Mellor PS, Rogers DJ, Samuel AR, Mertens PPC, Baylis M (2005) Climate change and the recent emergence of Bluetongue in Europe. Nat Rev Microbiol 3:171\u2013181. https:\/\/doi.org\/10.1038\/nrmicro1090","journal-title":"Nat Rev Microbiol"},{"key":"1753_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/j.1365-2672.2008.04036.x","volume":"106","author":"P Gale","year":"2009","unstructured":"Gale P, Drew T, Phipps LP, David G, Wooldridge M (2009) The effect of climate change on the occurrence and prevalence of livestock diseases in Great Britain: a review. J Appl Microbiol 106:1409\u20131423. https:\/\/doi.org\/10.1111\/j.1365-2672.2008.04036.x","journal-title":"J Appl Microbiol"},{"key":"1753_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.prevetmed.2008.06.005","volume":"87","author":"R Meiswinkel","year":"2008","unstructured":"Meiswinkel R, Baldet T, de Deken R, Takken W, Del\u00e9colle J-C, Mellor PS (2008) The 2006 outbreak of bluetongue in northern Europe\u2013the entomological perspective. Prev Vet Med 87:55\u201363. https:\/\/doi.org\/10.1016\/j.prevetmed.2008.06.005","journal-title":"Prev Vet Med"},{"key":"1753_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00436-007-0519-6","volume":"101","author":"H Mehlhorn","year":"2007","unstructured":"Mehlhorn H, Walldorf V, Klimpel S, Jahn B, Jaeger F, Eschweiler J, Hoffmann B, Beer M (2007) First occurrence of Culicoides obsoletus-transmitted Bluetongue Virus epidemic in Central Europe. Parasitol Res 101:219\u2013228. https:\/\/doi.org\/10.1007\/s00436-007-0519-6","journal-title":"Parasitol Res"},{"key":"1753_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/vr.162.13.422-a","volume":"162","author":"E Dijkstra","year":"2008","unstructured":"Dijkstra E, van der Ven IJK, Meiswinkel R, H\u00f6lzel DR, Van Rijn PA, Meiswinkel R (2008) Culicoides chiopterus as a potential vector of bluetongue virus in Europe. Vet Rec 162:422. https:\/\/doi.org\/10.1136\/vr.162.13.422-a","journal-title":"Vet Rec"},{"key":"1753_CR18","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/v16050766","volume":"16","author":"JS Benn","year":"2024","unstructured":"Benn JS, Orange JP, Gomez JP, Dinh ETN, McGregor BL, Blosser EM, Burkett-Cadena ND, Wisely SM, Blackburn JK (2024) Culicoides midge abundance across years: modeling inter-annual variation for an avian feeder and a candidate vector of hemorrhagic diseases in farmed wildlife. Viruses 16:766. https:\/\/doi.org\/10.3390\/v16050766","journal-title":"Viruses"},{"key":"1753_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13071-023-05799-w","volume":"16","author":"SE Allen","year":"2023","unstructured":"Allen SE, Vigil SL, Furukawa-Stoffer T, Colucci N, Ambagala A, Pearl DL, Ruder MG, Jardine CM, Nemeth NM (2023) Abundance and diversity of Culicoides Latreille (Diptera: Ceratopogonidae) in southern Ontario Canada. Parasite Vector 16:201. https:\/\/doi.org\/10.1186\/s13071-023-05799-w","journal-title":"Parasite Vector"},{"key":"1753_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12917-015-0435-4","volume":"11","author":"C Faverjon","year":"2015","unstructured":"Faverjon C, Leblond A, Hendrikx P, Balenghien T, de Vos CJ, Fischer EAJ, de Koeijer AA (2015) A spatiotemporal model to assess the introduction risk of African horse sickness by import of animals and vectors in France. BMC Vet Res 11:127. https:\/\/doi.org\/10.1186\/s12917-015-0435-4","journal-title":"BMC Vet Res"},{"key":"1753_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023066","volume":"6","author":"JA Backer","year":"2011","unstructured":"Backer JA, Nodelijk G (2011) Transmission and control of African Horse Sickness in The Netherlands: a model analysis. PLoS One 6:e23066. https:\/\/doi.org\/10.1371\/journal.pone.0023066","journal-title":"PLoS ONE"},{"key":"1753_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0378-1135(92)90041-Q","volume":"33","author":"M Rodriguez","year":"1992","unstructured":"Rodriguez M, Hooghuis H, Ma C (1992) African horse sickness in Spain. Vet Microbiol 33:129\u2013142. https:\/\/doi.org\/10.1016\/0378-1135(92)90041-Q","journal-title":"Vet Microbiol"},{"key":"1753_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev-ento-031616-035010","volume":"62","author":"S Carpenter","year":"2017","unstructured":"Carpenter S, Mellor PS, Fall AG, Garros C, Venter GJ (2017) African Horse Sickness Virus: history, transmission, and current status. Annu Rev Entomol 62:343\u2013358. https:\/\/doi.org\/10.1146\/annurev-ento-031616-035010","journal-title":"Annu Rev Entomol"},{"key":"1753_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/evj.13353","volume":"53","author":"J Castillo-Olivares","year":"2021","unstructured":"Castillo-Olivares J (2021) African Horse Sickness in Thailand: challenges of controlling an outbreak by vaccination. Equine Vet J 53:9\u201314. https:\/\/doi.org\/10.1111\/evj.13353","journal-title":"Equine Vet J"},{"key":"1753_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/tbed.12024","volume":"61","author":"N Aklilu","year":"2014","unstructured":"Aklilu N, Batten C, Gelaye E, Jenberie S, Ayelet G, Wilson A, Belay A, Asfaw Y, Oura C, Maan S, Bachanek-Bankowska K, Mertens PPC (2014) African Horse Sickness outbreaks caused by multiple virus types in Ethiopia. Transbound Emerg Dis 61:185\u2013192. https:\/\/doi.org\/10.1111\/tbed.12024","journal-title":"Transbound Emerg Dis"},{"key":"1753_CR26","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1016\/j.vaccine.2014.07.031","volume":"32","author":"Y Kanai","year":"2014","unstructured":"Kanai Y, van Rijn PA, Maris-Veldhuis M, Kaname Y, Athmaram TN, Roy P (2014) Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus. Vaccine 32:4932\u20134937. https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.031","journal-title":"Vaccine"},{"key":"1753_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1006\/viro.1993.1537","volume":"196","author":"TG Burrage","year":"1993","unstructured":"Burrage TG, Trevejo R, Stone-Marschat M, Laegreid WW (1993) Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2. Virology 196:799\u2013803. https:\/\/doi.org\/10.1006\/viro.1993.1537","journal-title":"Virology"},{"key":"1753_CR28","unstructured":"S.Karger AG (1972) Equine Infectious Diseases: 3rd International Conference. Medical and Scientific Publishers."},{"key":"1753_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/v11090844","author":"SJ Dennis","year":"2019","unstructured":"Dennis SJ, Meyers AE, Hitzeroth II, Rybicki EP (2019) African horse sickness: a review of current understanding and vaccine development. Viruses 11:844. https:\/\/doi.org\/10.3390\/v11090844","journal-title":"Viruses"},{"key":"1753_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1051\/vetres:2004021","volume":"35","author":"PS Mellor","year":"2004","unstructured":"Mellor PS, Hamblin C (2004) African Horse Sickness. Vet Res 35:445\u2013466. https:\/\/doi.org\/10.1051\/vetres:2004021","journal-title":"Vet Res"},{"key":"1753_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010323","volume":"5","author":"S Maan","year":"2010","unstructured":"Maan S, Maan NS, van Rijn PA, van Gennip RGP, Sanders A, Wright IM, Batten C, Hoffmann B, Eschbaumer M, Oura CAL, Potgieter AC, Nomikou K, Mertens PPC (2010) Full genome characterisation of Bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains. PLoS One 5:e10323. https:\/\/doi.org\/10.1371\/journal.pone.0010323","journal-title":"PLoS ONE"},{"key":"1753_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.virusres.2008.05.016","volume":"137","author":"CA Batten","year":"2008","unstructured":"Batten CA, Maan S, Shaw AE, Maan NS, Mertens PPC (2008) A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment. Virus Res 137:56\u201363. https:\/\/doi.org\/10.1016\/j.virusres.2008.05.016","journal-title":"Virus Res"},{"key":"1753_CR33","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3201\/eid2212.160718","volume":"22","author":"CT Weyer","year":"2016","unstructured":"Weyer CT, Grewar JD, Burger P, Rossouw E, Lourens C, Joone C, le Grange M, Coetzee P, Venter E, Martin DP, MacLachlan NJ, Guthrie AJ (2016) African Horse Sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004-2014. Emerg Infect Dis 22:2087\u20132096. https:\/\/doi.org\/10.3201\/eid2212.160718","journal-title":"Emerg Infect Dis"},{"key":"1753_CR34","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3390\/vaccines10071124","volume":"10","author":"L Jim\u00e9nez-Cabello","year":"2022","unstructured":"Jim\u00e9nez-Cabello L, Utrilla-Trigo S, Barreiro-Pi\u00f1eiro N, Pose-Boirazian T, Mart\u00ednez-Costas J, Mar\u00edn-L\u00f3pez A, Ortego J (2022) Nanoparticle- and microparticle-based vaccines against Orbiviruses of veterinary importance. Vaccines 10:1124. https:\/\/doi.org\/10.3390\/vaccines10071124","journal-title":"Vaccines"},{"issue":"Pt 9","key":"1753_CR35","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1099\/0022-1317-77-9-2053","volume":"77","author":"P Roy","year":"1996","unstructured":"Roy P, Bishop DH, Howard S, Aitchison H, Erasmus B (1996) Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge. J Gen Virol 77:2053\u20132057. https:\/\/doi.org\/10.1099\/0022-1317-77-9-2053","journal-title":"J Gen Virol"},{"key":"1753_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016503","volume":"6","author":"J Castillo-Olivares","year":"2011","unstructured":"Castillo-Olivares J, Calvo-Pinilla E, Casanova I, Bachanek-Bankowska K, Chiam R, Maan S, Nieto JM, Ortego J, Mertens PPC (2011) A Modified Vaccinia Ankara Virus (MVA) vaccine expressing African Horse Sickness Virus (AHSV) VP2 protects against AHSV challenge in an IFNAR \u2212\/\u2212 mouse model. PLoS One 6:e16503. https:\/\/doi.org\/10.1371\/journal.pone.0016503","journal-title":"PLoS ONE"},{"key":"1753_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.coviro.2020.05.003","volume":"44","author":"P Roy","year":"2020","unstructured":"Roy P (2020) Highly efficient vaccines for Bluetongue virus and a related Orbivirus based on reverse genetics. Curr Opin Virol 44:35\u201341. https:\/\/doi.org\/10.1016\/j.coviro.2020.05.003","journal-title":"Curr Opin Virol"},{"key":"1753_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coviro.2020.06.003","volume":"44","author":"E Calvo-Pinilla","year":"2020","unstructured":"Calvo-Pinilla E, Mar\u00edn-L\u00f3pez A, Utrilla-Trigo S, Jim\u00e9nez-Cabello L, Ortego J (2020) Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design. Curr Opin Virol 44:49\u201356. https:\/\/doi.org\/10.1016\/j.coviro.2020.06.003","journal-title":"Curr Opin Virol"},{"key":"1753_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2019.00407","volume":"6","author":"PA van Rijn","year":"2019","unstructured":"van Rijn PA (2019) Prospects of next-generation vaccines for Bluetongue. Front Vet Sci 6:407. https:\/\/doi.org\/10.3389\/fvets.2019.00407","journal-title":"Front Vet Sci"},{"key":"1753_CR40","doi-asserted-by":"publisher","first-page":"8764","DOI":"10.1128\/JVI.01052-15","volume":"89","author":"SGP van de Water","year":"2015","unstructured":"van de Water SGP, van Gennip RGP, Potgieter CA, Wright IM, van Rijn PA (2015) VP2 exchange and NS3\/NS3a deletion in African Horse Sickness Virus (AHSV) in development of Disabled Infectious Single Animal vaccine candidates for AHSV. J Virol 89:8764\u20138772. https:\/\/doi.org\/10.1128\/JVI.01052-15","journal-title":"J Virol"},{"key":"1753_CR41","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1016\/j.vaccine.2017.06.023","volume":"35","author":"V Lulla","year":"2017","unstructured":"Lulla V, Losada A, Lecollinet S, Kerviel A, Lilin T, Sailleau C, Beck C, Zientara S, Roy P (2017) Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge. Vaccine 35:4262\u20134269. https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.023","journal-title":"Vaccine"},{"key":"1753_CR42","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.vaccine.2018.03.003","volume":"36","author":"PA van Rijn","year":"2018","unstructured":"van Rijn PA, Maris-Veldhuis MA, Potgieter CA, van Gennip RGP (2018) African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3\/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform. Vaccine 36:1925\u20131933. https:\/\/doi.org\/10.1016\/j.vaccine.2018.03.003","journal-title":"Vaccine"},{"key":"1753_CR43","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1016\/j.vaccine.2018.05.044","volume":"36","author":"PA van Rijn","year":"2018","unstructured":"van Rijn PA, Maris-Veldhuis MA, Boonstra J, van Gennip RGP (2018) Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness. Vaccine 36:3584\u20133592. https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.044","journal-title":"Vaccine"},{"key":"1753_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/v13050857","volume":"13","author":"PA van Rijn","year":"2021","unstructured":"van Rijn PA, Maris-Veldhuis MA, van Gennip RGP (2021) The Bluetongue Disabled Infectious Single Animal (DISA) vaccine platform based on deletion NS3\/NS3a protein is safe and protective in cattle and enables DIVA. Viruses 13:857. https:\/\/doi.org\/10.3390\/v13050857","journal-title":"Viruses"},{"key":"1753_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101150","volume":"9","author":"PA van Rijn","year":"2021","unstructured":"van Rijn PA, Maris-Veldhuis MA, Spedicato M, Savini G, van Gennip RGP (2021) Pentavalent Disabled Infectious Single Animal (DISA)\/DIVA vaccine provides protection in sheep and cattle against different serotypes of bluetongue virus. Vaccines 9:1150. https:\/\/doi.org\/10.3390\/vaccines9101150","journal-title":"Vaccines"},{"key":"1753_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127772","volume":"64","author":"PA van Rijn","year":"2025","unstructured":"van Rijn PA, Wernery U, Feddema A-J, Maris-Veldhuis MA, Joseph S, van Gennip RGP (2025) Development of african horse sickness disabled infectious single animal (DISA)-DIVA vaccine platform applied for all nine serotypes. Vaccine 64:127772. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127772","journal-title":"Vaccine"},{"key":"1753_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044619","volume":"7","author":"RGP van Gennip","year":"2012","unstructured":"van Gennip RGP, van de Water SGP, Maris-Veldhuis M, van Rijn PA (2012) Bluetongue viruses based on modified-live vaccine Serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8. PLoS One 7:e44619. https:\/\/doi.org\/10.1371\/journal.pone.0044619","journal-title":"PLoS ONE"},{"key":"1753_CR48","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.95275","author":"L Jimenez-Cabello","year":"2024","unstructured":"Jimenez-Cabello L, Utrilla-Trigo S, Benavides J, Anguita J, Calvo-Pinilla E, Ortego J (2024) IFNAR(-\/-) mice constitutes a suitable animal model for epizootic hemorrhagic disease virus study and vaccine evaluation. Int J Biol Sci 20:3076-3093. https:\/\/doi.org\/10.7150\/ijbs.95275","journal-title":"Int J Biol Sci"},{"key":"1753_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005171","volume":"4","author":"E Calvo-Pinilla","year":"2009","unstructured":"Calvo-Pinilla E, Rodr\u00edguez-Calvo T, Anguita J, Sevilla N, Ortego J (2009) Establishment of a bluetongue virus infection model in mice that are deficient in the Alpha\/Beta Interferon Receptor. PLoS One 4:e5171. https:\/\/doi.org\/10.1371\/journal.pone.0005171","journal-title":"PLoS ONE"},{"key":"1753_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301340","volume":"19","author":"MM O\u2019Kennedy","year":"2024","unstructured":"O\u2019Kennedy MM, Roth R, Ebersohn K, du Plessis LH, Mamputha S, Rutkowska DA, du Preez I, Verschoor JA, Lemmer Y (2024) Immunogenic profile of a plant-produced nonavalent african horse sickness viral protein 2 (VP2) vaccine in IFNAR-\/- mice. PLoS One 19:e0301340. https:\/\/doi.org\/10.1371\/journal.pone.0301340","journal-title":"PLoS ONE"},{"key":"1753_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1114240","volume":"10","author":"LM Jones","year":"2023","unstructured":"Jones LM, Hawes PC, Salguero FJ, Castillo-Olivares J (2023) Pathological features of african horse sickness virus infection in IFNAR-\/- mice. Front Vet Sci 10:1114240. https:\/\/doi.org\/10.3389\/fvets.2023.1114240","journal-title":"Front Vet Sci"},{"key":"1753_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042065","volume":"25","author":"E Calvo-Pinilla","year":"2024","unstructured":"Calvo-Pinilla E, Jim\u00e9nez-Cabello L, Utrilla-Trigo S, Illescas-Amo M, Ortego J (2024) Cytokine mRNA expression profile in target organs of IFNAR (-\/-) mice infected with african horse sickness virus. Int J Mol Sci 25:2065. https:\/\/doi.org\/10.3390\/ijms25042065","journal-title":"Int J Mol Sci"},{"key":"1753_CR53","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"1753_CR54","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/104063870802000310","volume":"20","author":"M Ag\u00fcero","year":"2008","unstructured":"Ag\u00fcero M, G\u00f3mez-Tejedor C, Angeles Cubillo M, Rubio C, Romero E, Jim\u00e9nez-Clavero A (2008) Real-time fluorogenic reverse transcription polymerase chain reaction assay for detection of African horse sickness virus. J Vet Diagn Invest 20:325\u2013328. https:\/\/doi.org\/10.1177\/104063870802000310","journal-title":"J Vet Diagn Invest"},{"key":"1753_CR55","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nbt.1635","volume":"28","author":"AS Lauring","year":"2010","unstructured":"Lauring AS, Jones JO, Andino R (2010) Rationalizing the development of live attenuated virus vaccines. Nat Biotechnol 28:573\u2013579. https:\/\/doi.org\/10.1038\/nbt.1635","journal-title":"Nat Biotechnol"},{"key":"1753_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2021.108986","volume":"254","author":"Z Li","year":"2021","unstructured":"Li Z, Lu D, Yang H, Li Z, Zhu P, Xie J, Liao D, Zheng Y, Li H (2021) Bluetongue virus non-structural protein 3 (NS3) and NS4 coordinatively antagonize type I interferon signaling by targeting STAT1. Vet Microbiol 254:108986. https:\/\/doi.org\/10.1016\/j.vetmic.2021.108986","journal-title":"Vet Microbiol"},{"key":"1753_CR57","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1128\/jvi.00678-13","volume":"87","author":"E Chauveau","year":"2013","unstructured":"Chauveau E, Doceul V, Lara E, Breard E, Sailleau C, Vidalain P-O, Meurs EF, Dabo S, Schwartz-Cornil I, Zientara S, Vitour D (2013) NS3 of Bluetongue Virus interferes with the induction of Type I interferon. J Virol 87:8241\u20138246. https:\/\/doi.org\/10.1128\/jvi.00678-13","journal-title":"J Virol"},{"key":"1753_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198284","volume":"294","author":"SH Fearon","year":"2021","unstructured":"Fearon SH, Dennis SJ, Hitzeroth II, Rybicki EP, Meyers AE (2021) Humoral and cell-mediated immune responses to plant-produced African horse sickness virus VP7 quasi-crystals. Virus Res 294:198284. https:\/\/doi.org\/10.1016\/j.virusres.2020.198284","journal-title":"Virus Res"},{"key":"1753_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00938-18","volume":"92","author":"A Mar\u00edn-L\u00f3pez","year":"2018","unstructured":"Mar\u00edn-L\u00f3pez A, Calvo-Pinilla E, Barriales D, Lorenzo G, Brun A, Anguita J, Ortego J (2018) CD8 T cell responses to an immunodominant epitope within the nonstructural protein NS1 provide wide immunoprotection against Bluetongue Virus in IFNAR \u2212\/\u2212 mice. J Virol 92:e00938-18. https:\/\/doi.org\/10.1128\/JVI.00938-18","journal-title":"J Virol"},{"key":"1753_CR60","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.virusres.2015.08.005","volume":"210","author":"F de la Poza","year":"2015","unstructured":"de la Poza F, Mar\u00edn-L\u00f3pez A, Castillo-Olivares J, Calvo-Pinilla E, Ortego J (2015) Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(-\/-) mice. Virus Res 210:149\u2013153. https:\/\/doi.org\/10.1016\/j.virusres.2015.08.005","journal-title":"Virus Res"},{"key":"1753_CR61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.vetimm.2012.06.009","volume":"149","author":"H El Garch","year":"2012","unstructured":"El Garch H, Crafford JE, Amouyal P, Durand PY, Edlund Toulemonde C, Lemaitre L, Cozette V, Guthrie A, Minke JM (2012) An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses. Vet Immunol Immunopathol 149:76\u201385. https:\/\/doi.org\/10.1016\/j.vetimm.2012.06.009","journal-title":"Vet Immunol Immunopathol"},{"key":"1753_CR62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.01.009","volume":"116","author":"E Calvo-Pinilla","year":"2015","unstructured":"Calvo-Pinilla E, de la Poza F, Gubbins S, Mertens PPC, Ortego J, Castillo-Olivares J (2015) Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge. Antiviral Res 116:27\u201333. https:\/\/doi.org\/10.1016\/j.antiviral.2015.01.009","journal-title":"Antiviral Res"},{"issue":"Pt 6","key":"1753_CR63","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1099\/0022-1317-77-6-1211","volume":"77","author":"JL Mart\u00ednez-Torrecuadrada","year":"1996","unstructured":"Mart\u00ednez-Torrecuadrada JL, D\u00edaz-Laviada M, Roy P, S\u00e1nchez C, Vela C, S\u00e1nchez-Vizca\u00edno JM, Casal JI (1996) Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7. J Gen Virol 77:1211\u20131221. https:\/\/doi.org\/10.1099\/0022-1317-77-6-1211","journal-title":"J Gen Virol"},{"key":"1753_CR64","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1006\/viro.1996.0304","volume":"220","author":"MA Stone-Marschat","year":"1996","unstructured":"Stone-Marschat MA, Moss SR, Burrage TG, Barber ML, Roy P, Laegreid WW (1996) Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4. Virology 220:219\u2013222. https:\/\/doi.org\/10.1006\/viro.1996.0304","journal-title":"Virology"},{"key":"1753_CR65","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12917-020-02540-y","volume":"16","author":"M Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez M, Joseph S, Pfeffer M, Raghavan R, Wernery U (2020) Immune response of horses to inactivated African horse sickness vaccines. BMC Vet Res 16:322. https:\/\/doi.org\/10.1186\/s12917-020-02540-y","journal-title":"BMC Vet Res"},{"key":"1753_CR66","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.imbio.2015.09.002","volume":"221","author":"A Pretorius","year":"2016","unstructured":"Pretorius A, Faber FE, van Kleef M (2016) Immune gene expression profiling of PBMC isolated from horses vaccinated with attenuated African horsesickness virus serotype 4. Immunobiology 221:236\u2013244. https:\/\/doi.org\/10.1016\/j.imbio.2015.09.002","journal-title":"Immunobiology"},{"key":"1753_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virusres.2016.04.007","volume":"220","author":"FE Faber","year":"2016","unstructured":"Faber FE, van Kleef M, Tshilwane SI, Pretorius A (2016) African horse sickness virus serotype 4 antigens, VP1-1, VP2-2, VP4, VP7 and NS3, induce cytotoxic T cell responses in vitro. Virus Res 220:12\u201320. https:\/\/doi.org\/10.1016\/j.virusres.2016.04.007","journal-title":"Virus Res"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-026-01753-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-026-01753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-026-01753-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T08:58:09Z","timestamp":1779094689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13567-026-01753-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1186\/s13567-026-01753-7","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experimental protocols were approved by the Ethical Review Committee at the INIA-CISA and Comunidad de Madrid (Permit number: PROEX 075.2\/22) in strict accordance with EU guidelines 2010\/63\/UE about protection of animals used for experimentation, and other scientific purposes and Spanish Animal Welfare Act 32\/2007.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}